Role
Support
Description
This project involved Macrobiome contracting JCU to undertake R&D activities relating to the clinical development of two hookworm-derived proteins (MBT001 and MBT002) that are candidate drugs for the treatment of inflammatory bowel disease. The aim of this project is to acquire further data on the drug mechanism(s) of action (MOA) and efficacy is various pre-clinical models of colitis, as well as bioinformatically linking the MOA with the appropriate human disease population to target in future clinical trials.
Date
23 Oct 2025 - 31 Jan 2027
Project Type
N/A
Keywords
hookworm;colitis;drug development;inflammation
Funding Body
Macrobiome Therapeutics
Amount
1716560
Project Team
Kim Miles;Suchandan Sikder;Darren Pickering;Matt Field